TAG:
clinical trials
Pap Technology Wars Expected to Intensify
CEO SUMMARY: With patience and persistence, Digene, Inc. is developing the effectiveness of its DNA-based HPV assay. Publication of recently-completed clinical trials provides evidence that Digene’s Hybrid Capture II ® HPV test, with further improvement, might become a relevant tool in…
AmeriPath Pursues Ambitious Strategy Of Rapid Expansion
CEO SUMMARY: As the pathology profession’s only publicly-traded physician practice management company, AmeriPath is the spear point of far-reaching changes now transforming pathology. With an annual revenue run rate of $270 million and an ample war chest of growth capital, AmeriPath int…
Park City Solutions, DIANON, IMPATH American Med Labs, Cytyc, TriPath Imaging
PARK CITY SOLUTIONS AND AMERICAN MEDICAL LABS CREATE STRATEGIC PACT TWO COMPANIES FINANCED by GTCR Golder Rauner, LLC, the private equity firm based in Chicago, announced a strategic relationship. Park City Solutions, Inc. of Park City, Utah and Ame…
“State of Lab Industry” Holds Surprises for All
CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…
Lab Network in Florida Becoming Tough Player
CEO SUMMARY: Throughout the 1990s, a growing number of hospital laboratory administrators learned the value of a professionally-managed lab outreach program. In a few markets, these savvy lab leaders moved to the next level: using regional laboratory networks to solidify their local marke…
Specialty Labs Moving To Web-Based Services
CEO SUMMARY: Competition for hospital reference and esoteric testing remains intense. Three years ago, Specialty Laboratories made an early bet on Internet technology. It believed that being first to offer faster and less complicated access to laboratory informatics resources would give i…
Point-Of-Care Chemistry Ready To Transform Labs
CEO SUMMARY: Following on the heels of our prediction about web-based test ordering/results reporting, here’s another equally revolutionary development. CARESIDE, Inc. is ready to launch a point-of-care instrument suite for routine, high-volume chemistry and hematology tests. Early peek…
“November 1, 1999 Intelligence: Late Breaking Lab News”
Well-run hospital laboratory outreach programs continue to thrive. Last week THE DARK REPORT was in Chicago to visit Genesis Clinical Laboratory. Located in Berwyn, Illinois, Genesis is a for-profit subsidiary of McNeal Hospital. During the last two years, Genesis Pr…
Quest Holds Off on SBCL, Leaves the Door Open
CEO SUMMARY: It’s a cryptic situation as of press time. Quest Diagnostics issued a public statement on July 1 stating that its acquisition of SmithKline Beecham Clinical Laboratories would not close on July 2, as expected. Since that date, there’s been no further comment on the situat…
Surprise Merger Changes Cytology Marketplace
CEO SUMMARY: Expect the merger of AutoCyte, Inc. and NeoPath, Inc. to inaugurate a new market cycle for automated cytology systems. FDA approval of AutoCyte’s liquid preparation system, called PREP™, sets the stage for intensified marketing battles between the AutoCyte/NeoPath consort…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.